Home » Topics » Briefs » Other news to note

Other news to note
RSS

China's regulatory authority approves phase II trials of F-351

July 3, 2014

Actavis completes acquisition of Forest Laboratories, Furiex in favor of its acquisition

July 2, 2014

BioAlliance Pharma and Topotarget approve merger to create Onxeo

July 2, 2014

Auxilium plans merger with QLT

June 30, 2014

DART Therapeutics changes name

June 27, 2014

Lundbeck completes acquisition of Chelsea Therapeutics

June 26, 2014

Questcor Pharmaceuticals to acquire rights to Synacthen and Synacthen Depot

June 26, 2014

Allergan board of directors rejects exchange offer from Valeant Pharmaceuticals

June 25, 2014

Akorn sells subsidiary to Valeant Pharmaceuticals

June 25, 2014

Scripps Research Institute and T23 sign license for CD22 siglec oncoimmunological platform

June 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...